Tom Page
Partner
Clients rely on Tom’s advice in relation to all aspects of corporate law including ECM transactions, takeovers, M&A, JV’s and restructurings.
Partner
Clients rely on Tom’s advice in relation to all aspects of corporate law including ECM transactions, takeovers, M&A, JV’s and restructurings.
Language - English
Jurisdiction - England & Wales
Tom Page is a partner in the corporate team at Stephenson Harwood, specialising in corporate finance with a focus on capital markets, takeovers and private M&A.
A number of high profile companies have entrusted Tom to assist with their IPOs including Hotel Chocolat, easyHotel, Hornby and Manolete Partners. Tom also regularly acts for London mid-cap brokers on IPOs and secondary fundraisings (including placings, cash boxes and open offers) such as Stifel, Deutsche Numis, Cavendish and Panmure Liberum.
Tom is ranked in Chambers for Capital Markets: AIM and is a consultant editor of 'A Practitioner's Guide to the AIM Rules'.
Public takeover work includes buy-side such as advising Novacyt on its acquisition of Yourgene Health and sell-side such as advising easyHotel on its takeover by ICAMAP and CDPQ.
Private company M&A roles include advising De Vere on the sale of the Grand Hotel, Brighton and Snap-on Inc. on its acquisition of Norbar Torque Tools.
Tom has particular experience in the life sciences and healthcare sector and is a Recommended Lawyer in Legal 500 for Life Sciences & Healthcare. Tom has advised leading names in the sector such as Novacyt, BTG and Benevolent AI.
Novacyt S.A – takeover of Yourgene Health
Advised long-standing diagnostics client Novacyt in relation to its recommended takeover of Yourgene Health. The transaction was governed by the Takeover Code and effected by a court-sanctioned scheme of arrangement.
Manolete Partners - IPO
Advised Manolete Partners on its £76m AIM IPO and placing.
Numis and Argentex – IPO and secondaries
Advised Numis in its role as nominated adviser and broker on the AIM IPO of Argentex Group plc and related £46 million placing of new and existing shares.
Hotel Chocolat - IPO and secondaries
Advised Hotel Chocolat on its AIM IPO and secondary fundraisings.
Novacyt - IPO
Advised Paris-listed medical diagnostics company Novacyt on its dual listing on AIM.
BTG takeover of Biocompatibles
Advised on the £177 million takeover of Biocompatibles plc.
BTG cash box placing for acquisition of PneumRx Inc
Advised on BTG’s £160m joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.
Siem Industries S.A.
Advised Siem in relation to the $4.7 billion EU cross-border merger between Saipem and Subsea 7.
easyHotel – IPO, secondaries, takeover
Advised easyHotel on its AIM IPO, subsequent secondary fundraisings, takeover and de-listing.
AIM Group Ltd – sale to Liberty Hall
Sale of US operations and UK holding company of aviation manufacturing business AIM Group to buyer backed by Liberty Hall Capital for US$220 million.
